523 related articles for article (PubMed ID: 16818950)
1. Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor-positive tumors.
Bettio A; Honer M; Müller C; Brühlmeier M; Müller U; Schibli R; Groehn V; Schubiger AP; Ametamey SM
J Nucl Med; 2006 Jul; 47(7):1153-60. PubMed ID: 16818950
[TBL] [Abstract][Full Text] [Related]
2. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
3. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.
Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR
Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506
[TBL] [Abstract][Full Text] [Related]
4. Isostructural folate conjugates radiolabeled with the matched pair 99mTc/188Re: a potential strategy for diagnosis and therapy of folate receptor-positive tumors.
Müller C; Schubiger PA; Schibli R
Nucl Med Biol; 2007 Aug; 34(6):595-601. PubMed ID: 17707798
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of (99m)Tc-DO3A-EA-Folate for receptor-mediated targeting of folate positive tumors.
Mishra G; Hazari PP; Kumar N; Mishra AK
J Drug Target; 2011 Nov; 19(9):761-9. PubMed ID: 21425922
[TBL] [Abstract][Full Text] [Related]
6. A new 18F-labeled folic acid derivative with improved properties for the PET imaging of folate receptor-positive tumors.
Ross TL; Honer M; Müller C; Groehn V; Schibli R; Ametamey SM
J Nucl Med; 2010 Nov; 51(11):1756-62. PubMed ID: 20956469
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 2'-deoxy-2'-18F-fluoro-5-fluoro-1-beta-D-arabinofuranosyluracil as a potential PET imaging agent for suicide gene expression.
Alauddin MM; Shahinian A; Park R; Tohme M; Fissekis JD; Conti PS
J Nucl Med; 2004 Dec; 45(12):2063-9. PubMed ID: 15585483
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro/in vivo evaluation of novel 99mTc(CO)3-folates.
Müller C; Schubiger PA; Schibli R
Bioconjug Chem; 2006; 17(3):797-806. PubMed ID: 16704220
[TBL] [Abstract][Full Text] [Related]
9. [18F]fluoro-deoxy-glucose folate: a novel PET radiotracer with improved in vivo properties for folate receptor targeting.
Fischer CR; Müller C; Reber J; Müller A; Krämer SD; Ametamey SM; Schibli R
Bioconjug Chem; 2012 Apr; 23(4):805-13. PubMed ID: 22372827
[TBL] [Abstract][Full Text] [Related]
10. First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography.
Schottelius M; Poethko T; Herz M; Reubi JC; Kessler H; Schwaiger M; Wester HJ
Clin Cancer Res; 2004 Jun; 10(11):3593-606. PubMed ID: 15173065
[TBL] [Abstract][Full Text] [Related]
11. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
[TBL] [Abstract][Full Text] [Related]
12. BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors.
Gibbs DD; Theti DS; Wood N; Green M; Raynaud F; Valenti M; Forster MD; Mitchell F; Bavetsias V; Henderson E; Jackman AL
Cancer Res; 2005 Dec; 65(24):11721-8. PubMed ID: 16357184
[TBL] [Abstract][Full Text] [Related]
13. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
[TBL] [Abstract][Full Text] [Related]
14. Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo.
Leamon CP; Cooper SR; Hardee GE
Bioconjug Chem; 2003; 14(4):738-47. PubMed ID: 12862426
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy.
Shukla S; Wu G; Chatterjee M; Yang W; Sekido M; Diop LA; Müller R; Sudimack JJ; Lee RJ; Barth RF; Tjarks W
Bioconjug Chem; 2003; 14(1):158-67. PubMed ID: 12526705
[TBL] [Abstract][Full Text] [Related]
16. Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors.
Lu Y; Low PS
Cancer Immunol Immunother; 2002 May; 51(3):153-62. PubMed ID: 11941454
[TBL] [Abstract][Full Text] [Related]
17. Effects of the antifolates pemetrexed and CB3717 on the tissue distribution of (99m)Tc-EC20 in xenografted and syngeneic tumor-bearing mice.
Müller C; Reddy JA; Leamon CP; Schibli R
Mol Pharm; 2010 Apr; 7(2):597-604. PubMed ID: 20199053
[TBL] [Abstract][Full Text] [Related]
18. Folate-PEG-NOTA-Al
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2017 Dec; 14(12):4353-4361. PubMed ID: 29028357
[TBL] [Abstract][Full Text] [Related]
19. Pteroyl-gamma-glutamate-cysteine synthesis and its application in folate receptor-mediated cancer cell targeting using folate-tethered liposomes.
Zhang Y; Guo L; Roeske RW; Antony AC; Jayaram HN
Anal Biochem; 2004 Sep; 332(1):168-77. PubMed ID: 15301962
[TBL] [Abstract][Full Text] [Related]
20. Radioiodinated folic acid conjugates: evaluation of a valuable concept to improve tumor-to-background contrast.
Reber J; Struthers H; Betzel T; Hohn A; Schibli R; Müller C
Mol Pharm; 2012 May; 9(5):1213-21. PubMed ID: 22509996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
